FISV · Insider Trading
Fiserv, Inc. Common Stock
Every open-market purchase and sale reported by FISV officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Harry DiSimone | Director | A | +775 deriv. | — |
| 2026-10-01 | Charlotte Yarkoni | Director | A | +748 deriv. | — |
| 2026-10-01 | Wafaa Mamilli | Director | A | +858 deriv. | — |
| 2026-10-01 | Gordon M. Nixon | Director | A | +1,107 deriv. | — |
| 2026-10-01 | Stephanie Cohen | Director | A | +775 deriv. | — |
| 2026-10-01 | Lance M Fritz | Director | A | +858 deriv. | — |
| 2026-10-01 | Henrique De Castro | Director | A | +720 deriv. | — |
| 2026-10-01 | Ajei Gopal | Director | A | +831 deriv. | — |
| 2026-10-01 | Celine S Dufetel | Director | A | +775 deriv. | — |
| 2026-10-01 | Gary Shedlin | Director | A | +886 deriv. | — |
| 2026-09-18 | Paul M Todd | Chief Financial Officer | F | −795 | −$39.19K |
| 2026-08-11 | Lance M Fritz | Director | Buy | +10,000 | +$519.50K |
| 2026-08-03 | Adam L. Rosman | Chief Admin. and Legal Officer | A | +36,799 | — |
| 2026-07-01 | Stephanie Cohen | Director | A | +663 deriv. | — |
| 2026-07-01 | Gordon M. Nixon | Director | A | +892 deriv. | — |
| 2026-07-01 | Gary Shedlin | Director | A | +791 deriv. | — |
| 2026-07-01 | Henrique De Castro | Director | A | +663 deriv. | — |
| 2026-07-01 | Wafaa Mamilli | Director | A | +765 deriv. | — |
| 2026-07-01 | Harry DiSimone | Director | A | +663 deriv. | — |
| 2026-07-01 | Lance M Fritz | Director | A | +765 deriv. | — |
| 2026-07-01 | Ajei Gopal | Director | A | +765 deriv. | — |
| 2026-07-01 | Charlotte Yarkoni | Director | A | +663 deriv. | — |
| 2026-07-01 | Celine S Dufetel | Director | A | +663 deriv. | — |
| 2026-06-18 | Paul M Todd | Chief Financial Officer | Buy | +10,060 | +$499.98K |
| 2026-06-17 | Wafaa Mamilli | Director | Buy | +2,960 | +$149.75K |
| 2026-06-16 | Adam L. Rosman | Chief Admin. and Legal Officer | Buy | +10,150 | +$500.70K |
| 2026-06-16 | Gordon M. Nixon | Director | Buy | +7,500 | +$371.77K |
| 2026-06-16 | Paul M Todd | Chief Financial Officer | A | +104,363 | — |
| 2026-06-16 | Charlotte Yarkoni | Director | Buy | +2,023 | +$100.12K |
| 2026-06-16 | Panagiotis Georgakopoulos | Chief Executive Officer | A | +50,094 | — |
| 2026-06-16 | Harry DiSimone | Director | Buy | +2,088 | +$101.08K |
| 2026-05-22 | Stephanie Cohen | Director | A | +4,121 | — |
| 2026-05-22 | Henrique De Castro | Director | A | +4,121 | — |
| 2026-05-22 | Harry DiSimone | Director | A | +4,121 | — |
| 2026-05-22 | Celine S Dufetel | Director | A | +4,121 | — |
| 2026-05-22 | Lance M Fritz | Director | A | +4,121 | — |
| 2026-05-22 | Ajei Gopal | Director | A | +4,121 | — |
| 2026-05-22 | Wafaa Mamilli | Director | A | +4,121 | — |
| 2026-05-22 | Gordon M. Nixon | Director | A | +5,913 | — |
| 2026-05-22 | Gary Shedlin | Director | A | +4,121 | — |
| 2026-05-22 | Charlotte Yarkoni | Director | A | +4,121 | — |
| 2026-04-02 | Stephanie Cohen | Director | A | +583 deriv. | — |
| 2026-04-02 | Henrique De Castro | Director | A | +583 deriv. | — |
| 2026-04-02 | Harry DiSimone | Director | A | +583 deriv. | — |
| 2026-04-02 | Celine S Dufetel | Director | A | +583 deriv. | — |
| 2026-04-02 | Lance M Fritz | Director | A | +673 deriv. | — |
| 2026-04-02 | Gordon M. Nixon | Director | A | +785 deriv. | — |
| 2026-04-02 | Ajei Gopal | Director | A | +673 deriv. | — |
| 2026-04-02 | Wafaa Mamilli | Director | A | +673 deriv. | — |
| 2026-04-02 | Gary Shedlin | Director | A | +695 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Frank Bisignano | Chairman and CEO | 3,410,762 | $215.49M |
| Michael P. Lyons | Chief Executive Officer | 351,317 | $22.20M |
| Panagiotis Georgakopoulos | Chief Executive Officer | 303,868 | $19.20M |
| Guy Chiarello | Chief Operating Officer | 260,666 | $16.47M |
| Dhivya Suryadevara | Co-President | 228,463 | $14.43M |
| Robert W. Hau | Chief Financial Officer | 184,179 | $11.64M |
| Paul M Todd | Chief Financial Officer | 183,312 | $11.58M |
| Adam L. Rosman | Chief Admin. and Legal Officer | 173,523 | $10.96M |
| Andrew Gelb | EVP, Head of Fin. Sols. | 91,566 | $5.79M |
| Doyle Simons | Director | 77,788 | $4.91M |
| Kenneth Best | Chief Accounting Officer | 64,586 | $4.08M |
| Heidi Miller | Director | 36,265 | $2.29M |
| Jennifer A. LaClair | EVP, Head of Merchant Sols. | 29,010 | $1.83M |
| Henrique De Castro | Director | 28,233 | $1.78M |
| John Gibbons | EVP, Head of Fin. Insts. Grp. | 27,602 | $1.74M |
| Lance M Fritz | Director | 27,207 | $1.72M |
| Harry DiSimone | Director | 26,313 | $1.66M |
| Gordon M. Nixon | Director | 17,656 | $1.12M |
| Wafaa Mamilli | Director | 15,386 | $972.09K |
| Charlotte Yarkoni | Director | 10,146 | $641.02K |
| Kevin M Warren | Director | 9,483 | $599.14K |
| Ajei Gopal | Director | 7,329 | $463.05K |
| Stephanie Cohen | Director | 5,510 | $348.12K |
| Celine S Dufetel | Director | 5,435 | $343.38K |
| Gary Shedlin | Director | 5,435 | $343.38K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the FISV quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.